<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T14:46:48Z</responseDate>
  <request identifier="oai:figshare.com:article/33815223" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33815223</identifier>
        <datestamp>2026-09-15T18:05:11Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Association between glycaemic status and clinical symptoms among study participants before the start of TB treatment.&lt;/p&gt;</dc:title>
          <dc:creator>Victor Moses Musyoki (14783149)</dc:creator>
          <dc:creator>Marianne Mureithi (6648431)</dc:creator>
          <dc:creator>Annamari Heikinheimo (125624)</dc:creator>
          <dc:creator>Elizabeth Maleche-Obimbo (219132)</dc:creator>
          <dc:creator>Dishon Maina (24950622)</dc:creator>
          <dc:creator>Susan Musau (3214734)</dc:creator>
          <dc:creator>Ruth Maganga (19890912)</dc:creator>
          <dc:creator>Omu Anzala (10435)</dc:creator>
          <dc:creator>Kariuki Njaanake (14334330)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>known diabetes mellitus</dc:subject>
          <dc:subject>generalized estimating equations</dc:subject>
          <dc:subject>adults newly diagnosed</dc:subject>
          <dc:subject>65 &amp;# 8211</dc:subject>
          <dc:subject>38 &amp;# 8211</dc:subject>
          <dc:subject>20 &amp;# 8211</dc:subject>
          <dc:subject>12 &amp;# 8211</dc:subject>
          <dc:subject>09 &amp;# 8211</dc:subject>
          <dc:subject>experience classic symptoms</dc:subject>
          <dc:subject>integrate glycaemic monitoring</dc:subject>
          <dc:subject>persisting sputum positivity</dc:subject>
          <dc:subject>adjusted relative risk</dc:subject>
          <dc:subject>24 &amp;# 8211</dc:subject>
          <dc:subject>xlink "&gt; new</dc:subject>
          <dc:subject>classic diabetic symptoms</dc:subject>
          <dc:subject>incident hyperglycaemia based</dc:subject>
          <dc:subject>five time points</dc:subject>
          <dc:subject>routine tb follow</dc:subject>
          <dc:subject>tb treatment outcomes</dc:subject>
          <dc:subject>time points</dc:subject>
          <dc:subject>sputum positivity</dc:subject>
          <dc:subject>treatment outcomes</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>related symptoms</dc:subject>
          <dc:subject>glycaemic variability</dc:subject>
          <dc:subject>glycaemic status</dc:subject>
          <dc:subject>tb treatment</dc:subject>
          <dc:subject>temporal patterns</dc:subject>
          <dc:subject>structured questionnaire</dc:subject>
          <dc:subject>previously diabetic</dc:subject>
          <dc:subject>predominantly male</dc:subject>
          <dc:subject>longitudinal trends</dc:subject>
          <dc:subject>longitudinal measurements</dc:subject>
          <dc:subject>insulin resistance</dc:subject>
          <dc:subject>highly prevalent</dc:subject>
          <dc:subject>gee analysis</dc:subject>
          <dc:subject>friedman test</dc:subject>
          <dc:subject>frequent micturition</dc:subject>
          <dc:subject>disease presentation</dc:subject>
          <dc:subject>confidence interval</dc:subject>
          <dc:subject>collected using</dc:subject>
          <dc:subject>burden settings</dc:subject>
          <dc:subject>blurred vision</dc:subject>
          <dc:subject>alcohol use</dc:subject>
          <dc:subject>additional death</dc:subject>
          <dc:subject>53 %),</dc:subject>
          <dc:subject>52 ).</dc:subject>
          <dc:subject>44 ).</dc:subject>
          <dc:description>&lt;p&gt;Association between glycaemic status and clinical symptoms among study participants before the start of TB treatment.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-15T18:05:05Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0358593.t002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Association_between_glycaemic_status_and_clinical_symptoms_among_study_participants_before_the_start_of_TB_treatment_p_/33815223</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
